HFM Investment Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237 Sell
5
-2
-29% -$103 ﹤0.01% 1161
2026
Q1
$415 Buy
7
+4
+133% +$260 ﹤0.01% 742
2025
Q4
$186 Sell
3
-1
-25% -$61 ﹤0.01% 1045
2025
Q3
$250 Hold
4
﹤0.01% 925
2025
Q2
$319 Buy
4
+2
+100% +$167 ﹤0.01% 824
2025
Q1
$172 Buy
+2
New +$164 ﹤0.01% 687

Other funds holding PBH

HFM Investment Advisors's PBH Position: Q2 2026 in Review

HFM Investment Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 29% in Q2 2026, selling an estimated $103 and leaving 5 shares worth $237. The position accounts for ﹤0.01% of the portfolio, ranked #1161.

HFM Investment Advisors first reported a position in PBH in Q1 2025 and has held it in 6 quarters since. The position peaked at $415 in Q1 2026. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • HFM Investment Advisors held 5 shares of Prestige Consumer Healthcare worth $237 as of Q2 2026.
  • HFM Investment Advisors sold 2 Prestige Consumer Healthcare shares in Q2 2026, an estimated $103.
  • Prestige Consumer Healthcare made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #1161 holding.
  • HFM Investment Advisors first reported a position in Prestige Consumer Healthcare in Q1 2025 and has held it in 6 quarters since.
  • HFM Investment Advisors's Prestige Consumer Healthcare position peaked at $415 in Q1 2026.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.